Adicet Bio, Inc.
Adicet Bio, Inc.（ACET）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · ACET · 截至 2026年6月9日
活动摘要
买入笔数
5
P-Purchase only
卖出笔数
4
近12个月
买卖比
1.25
Buy/Sell (by trades)
整体情绪
Adicet Bio, Inc.内部人在过去近12个月净买入股份，可能反映对公司前景的信心。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
ACET 季度内部人买卖趋势
ACET 内幕交易卖出 · ACET 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · ACET CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
ACET 高管卖出股份 · ACET 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Apr 27, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Other | 250,000 | $25 | Form 4 |
| Feb 20, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Purchase | 74,751 | $543K | Form 4 |
| Feb 19, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Purchase | 74,268 | $535K | Form 4 |
| Feb 18, 2026 | RA CAPITAL MANAGEMENT, L.P. 10 percent owner | Purchase | 74,577 | $525K | Form 4 |
| Apr 7, 2026 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 29,319 | $191K | Form 4 |
| Apr 7, 2026 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 2,400 | $15K | Form 4 |
| Apr 8, 2026 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 32,523 | $205K | Form 4 |
| Apr 8, 2026 | ORBIMED ADVISORS LLC 10 percent owner | Sale | 40,416 | $264K | Form 4 |
| Jan 24, 2026 | Aftab Blake Chief Scientific Officer | Other | 535 | $5K | Form 4 |
| Jan 24, 2026 | Healey Don CTO | Other | 535 | $5K | Form 4 |
| Jan 24, 2026 | Schor Chen President & CEO · Director | Other | 1,755 | $15K | Form 4 |
| Jan 24, 2026 | Harvey Brian Nicholas CFO | Other | 546 | $5K | Form 4 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC 10 percent owner | Purchase | 1,500,000 | $1.50M⚡ | Form 4 |
| Oct 8, 2025 | ORBIMED ADVISORS LLC 10 percent owner | Purchase | 3,500,000 | $3.50M⚡ | Form 4 |
| Jun 11, 2025 | Klickstein Lloyd Director | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Chodakewitz Jeffrey Director | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | DUBIN STEVE Director | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Peng Katie Director | Award | 5,900 | — | Form 4 |
| Jun 11, 2025 | Sinclair Andrew Director | Award | 5,900 | — | Form 4 |
| Jan 24, 2025 | Schor Chen President & CEO · Director | Other | 28,101 | $26K | Form 4 |
| Jan 24, 2025 | Healey Don CTO | Other | 8,560 | $8K | Form 4 |
| Jan 24, 2025 | Aftab Blake Chief Scientific Officer | Other | 6,270 | $6K | Form 4 |
| Jan 24, 2025 | Harvey Brian Nicholas CFO | Other | 8,752 | $8K | Form 4 |
| Jun 5, 2024 | GORDON CARL L Director | Award | 5,900 | — | Form 4 |
| Jun 5, 2024 | Chodakewitz Jeffrey Director | Award | 5,900 | — | Form 4 |
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
日期
Apr 27
股数
250,000
均价
$0.00
总金额
$25
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
日期
Feb 20
股数
74,751
均价
$7.27
总金额
$543K
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
日期
Feb 19
股数
74,268
均价
$7.21
总金额
$535K
RA CAPITAL MANAGEMENT, L.P.
10 percent owner
日期
Feb 18
股数
74,577
均价
$7.04
总金额
$525K
ORBIMED ADVISORS LLC
10 percent owner
日期
Oct 8
股数
1,500,000
均价
$1.00
总金额
$1.50M ⚡
ORBIMED ADVISORS LLC
10 percent owner
日期
Oct 8
股数
3,500,000
均价
$1.00
总金额
$3.50M ⚡
⚡ = 金额≥$100万 · Award/Option价格显示— · 仅Form4 · 仅普通股
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 ACET 内幕交易
ACET 内幕交易
Adicet Bio, Inc.（ACET）内幕交易数据来源于公司内部人（包括ORBIMED ADVISORS LLC (10 percent owner), RA CAPITAL MANAGEMENT, L.P. (10 percent owner), Aftab Blake (Chief Scientific Officer)）提交的SEC Form 4申报文件。过去12个月内，5位内部人向SEC提交了交易申报。ACET内部人近期主要在买入，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Adicet Bio, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
ACET 内幕交易 · 5个问题Adicet Bio, Inc.（ACET）的内部人包括高管和董事，如ORBIMED ADVISORS LLC (10 percent owner), RA CAPITAL MANAGEMENT, L.P. (10 percent owner), Aftab Blake (Chief Scientific Officer)等。过去12个月内，5位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026